UPDATE: JPMorgan Upgrades Karyopharm Therapeutics (KPTI) to Neutral
Tweet Send to a Friend
(Updated - February 9, 2022 1:01 AM EST)
JPMorgan analyst Eric Joseph upgraded Karyopharm Therapeutics (NASDAQ: KPTI) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph upgraded Karyopharm Therapeutics (NASDAQ: KPTI) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
